Rondinone, Cristina M.

LEAP2 Is an Endogenous Antagonist of the Ghrelin Receptor

Ge, X., Yang, H., Bednarek, M. A., Galon-Tilleman, H., Chen, P., Chen, M., Lichtman, J. S., Wang, Y., Dalmas, O., Yin, Y., et al. (2018) · Cell Metabolism

Regulation of Appetite and ObesityNeuropeptides and Animal Physiology

Cited by 376

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

Ambery, P., Parker, V. E., Stumvoll, M., Posch, M. G., Heise, T., Plum-Moerschel, L., Tsai, L.-F., Robertson, D., Jain, M., Petrone, M., et al. (2018) · The Lancet

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 298

Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis

Boland, M. L., Laker, R. C., Mather, K., Nawrocki, A., Oldham, S., Boland, B. B., Lewis, H., Conway, J., Naylor, J., Guionaud, S., et al. (2020) · Nature Metabolism

Liver Disease Diagnosis and TreatmentDiabetes Treatment and Management

Cited by 270

Robust anti‐obesity and metabolic effects of a dual GLP ‐1/glucagon receptor peptide agonist in rodents and non‐human primates

Henderson, S. J., Konkar, A., Hornigold, D. C., Trevaskis, J. L., Jackson, R., Fritsch Fredin, M., Jansson‐Löfmark, R., Naylor, J., Rossi, A., Bednarek, M. A., et al. (2016) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementRegulation of Appetite and Obesity

Cited by 240

Aldosterone stimulated differentiation of mouse 3T3-L1 cells into adipocytes

Rondinone, C. M., Rodbard, D., & Baker, M. E. (1993) · Endocrinology

Adipose Tissue and MetabolismHormonal Regulation and Hypertension

Cited by 101

A novel glucagon-like peptide 1/glucagon receptor dual agonist improves steatohepatitis and liver regeneration in mice

Valdecantos, M. P., Pardo, V., Ruiz, L., Castro‐Sánchez, L., Lanzón, B., Fernández‐Millán, E., García‐Monzón, C., Arroba, A. I., González‐Rodríguez, Á., Escrivá, F., et al. (2017) · Hepatology

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 100

MEDI0382, a GLP‐1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single‐dose, healthy‐subject, randomized, Phase 1 study

Ambery, P. D., Klammt, S., Posch, M. G., Petrone, M., Pu, W., Rondinone, C., Jermutus, L., & Hirshberg, B. (2018) · British Journal of Clinical Pharmacology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 75

RNA interference to target lipid disorders

Rondinone, C. M. (2008) · Current Opinion in Lipidology

RNA Interference and Gene DeliveryLipoproteins and Cardiovascular Health

Cited by 2

85-OR: A Novel Unimolecular Peptide Tetra-agonist (PTT-A) Targeting GLP-1, GIP, Amylin, and Calcitonin Receptors with Superior Weight Loss Effects vs. Tirzepatide While Preserving Muscle in DIO Rats

GHOSH, S., VALDECANTOS, P., RADA, P., VALVERDE, A. M., & RONDINONE, C. M. (2025) · Diabetes

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 2